Concepedia

Julie Kerby

JK

Statistics

Publications

19

Citations

3.2K

H-Index

19

Active since

1991

Affiliations

MSD (UK) Limited (United Kingdom)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Pfizer (United Kingdom)

University of Cambridge

University College London

Julie Kerby is an author at MSD (UK) Limited (United Kingdom) specializing in life sciences, cell biology, and pharmacology.

Publications per year

1991–2018

19

Publications

19

Phase 1 clinical study of an embryonic stem cell–derived retinal pigment epithelium patch in age-related macular degeneration

Lyndon da Cruz, Kate Fynes, Odysseas Georgiadis et al. · Nature Biotechnology · 2018 · 720 citations

, , +17

Pharmacological characterization of a novel cell line expressing human <i>α</i><sub>4</sub><i>β</i><sub>3</sub><i>δ</i> GABA<sub>A</sub> receptors

N. Brown, Julie Kerby, Timothy P. Bonnert et al. · British Journal of Pharmacology · 2002 · 602 citations · Full text

, , +17

Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.

Tony Priestley, Petra Laughton, Jan Myers et al. · Molecular Pharmacology · 1995 · 259 citations

, , +17

Preferential Coassembly of α4 and δ Subunits of the γ-Aminobutyric Acid<sub>A</sub>Receptor in Rat Thalamus

Cyrille Sur, Sophie J. Farrar, Julie Kerby et al. · Molecular Pharmacology · 1999 · 229 citations

, , +17

α4β3δ GABAAReceptors Characterized by Fluorescence Resonance Energy Transfer-derived Measurements of Membrane Potential

Charles Adkins, Gopalan V. Pillai, Julie Kerby et al. · Journal of Biological Chemistry · 2001 · 192 citations · Full text

, , +16

1–5 of 19